Skip to content
The Nexus
DossierENTITY

Pharmacal

Coverage of Pharmacal in the Nexus archive.

Earliest in view: May 13 · 11:10 UTCMost recent: May 13 · 11:10 UTC
Co-mentioned in this coverage
Food and Drug Administrationorganization1MG217topic1Staphylococcus aureustopic1Wisconsinplace1
Recent coverage
  • HEALTHMay 13 · 11:10 UTCKTLA 5
    Eczema cream recalled over risk of 'life-threatening' staph infection

    A Wisconsin company is recalling a cream used to treat eczema due to contamination with Staphylococcus aureus. The recall was announced by the Food and Drug Administration on Tuesday. The contaminated product is Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold under the brand name MG217 by Pharmacal.